Global Blood Bank (Blood Banking) Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term 'blood bank' typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.
According to APO Research, The global Blood Bank (Blood Banking) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North America is the largest consumption place, with a consumption market share more than 35%, It was followed by Europe with 25%. Shire (Baxalta), CSL and Grifols are the top 3 players of Blood Bank market, and they had a nearly 60% combined market share.
This report presents an overview of global market for Blood Bank (Blood Banking), revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Blood Bank (Blood Banking), also provides the value of main regions and countries. Of the upcoming market potential for Blood Bank (Blood Banking), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Bank (Blood Banking) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Blood Bank (Blood Banking) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Descriptive company profiles of the major global players, including American Red Cross, Japan Red Cross Society, New York Blood Center, Sanquin Blood Supply Foundation, America’s Blood Centers, Canadian Blood Services, Shire (Baxalta), CSL and Grifols, etc.
Blood Bank (Blood Banking) segment by Company
1. To analyze and research the global Blood Bank (Blood Banking) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Blood Bank (Blood Banking) key companies, revenue, market share, and recent developments.
3. To split the Blood Bank (Blood Banking) breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Blood Bank (Blood Banking) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blood Bank (Blood Banking) significant trends, drivers, influence factors in global and regions.
6. To analyze Blood Bank (Blood Banking) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Bank (Blood Banking) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Bank (Blood Banking) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Bank (Blood Banking).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Bank (Blood Banking) industry.
Chapter 3: Detailed analysis of Blood Bank (Blood Banking) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Blood Bank (Blood Banking) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Blood Bank (Blood Banking) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Chapter 9: Concluding Insights.
According to APO Research, The global Blood Bank (Blood Banking) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North America is the largest consumption place, with a consumption market share more than 35%, It was followed by Europe with 25%. Shire (Baxalta), CSL and Grifols are the top 3 players of Blood Bank market, and they had a nearly 60% combined market share.
This report presents an overview of global market for Blood Bank (Blood Banking), revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Blood Bank (Blood Banking), also provides the value of main regions and countries. Of the upcoming market potential for Blood Bank (Blood Banking), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Blood Bank (Blood Banking) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Blood Bank (Blood Banking) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global @@@@ company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Descriptive company profiles of the major global players, including American Red Cross, Japan Red Cross Society, New York Blood Center, Sanquin Blood Supply Foundation, America’s Blood Centers, Canadian Blood Services, Shire (Baxalta), CSL and Grifols, etc.
Blood Bank (Blood Banking) segment by Company
- American Red Cross
- Japan Red Cross Society
- New York Blood Center
- Sanquin Blood Supply Foundation
- America’s Blood Centers
- Canadian Blood Services
- Shire (Baxalta)
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Sichuan Yuanda Shuyang
- Abbott
- Beckman Coulter
- BD
- Bio-Rad Laboratories
- bioMйrieux
- Cerus
- Haemonetics
- Immucor
- Fresenius Kabi
- MacoPharma
- Ortho-Clinical
- Terumo BCT
- Whole Blood
- Red Blood Cell
- Platelet
- Plasma
- White Blood Cell
- Hospital
- Clinic
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Blood Bank (Blood Banking) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Blood Bank (Blood Banking) key companies, revenue, market share, and recent developments.
3. To split the Blood Bank (Blood Banking) breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Blood Bank (Blood Banking) market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Blood Bank (Blood Banking) significant trends, drivers, influence factors in global and regions.
6. To analyze Blood Bank (Blood Banking) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Bank (Blood Banking) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Blood Bank (Blood Banking) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Bank (Blood Banking).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Bank (Blood Banking) industry.
Chapter 3: Detailed analysis of Blood Bank (Blood Banking) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Blood Bank (Blood Banking) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Blood Bank (Blood Banking) in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
Chapter 9: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Blood Bank (Blood Banking) Market Size, 2019 VS 2023 VS 2030
1.3 Global Blood Bank (Blood Banking) Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 BLOOD BANK (BLOOD BANKING) MARKET DYNAMICS
2.1 Blood Bank (Blood Banking) Industry Trends
2.2 Blood Bank (Blood Banking) Industry Drivers
2.3 Blood Bank (Blood Banking) Industry Opportunities and Challenges
2.4 Blood Bank (Blood Banking) Industry Restraints
3 BLOOD BANK (BLOOD BANKING) MARKET BY COMPANY
3.1 Global Blood Bank (Blood Banking) Company Revenue Ranking in 2023
3.2 Global Blood Bank (Blood Banking) Revenue by Company (2019-2024)
3.3 Global Blood Bank (Blood Banking) Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Blood Bank (Blood Banking) Company Manufacturing Base & Headquarters
3.5 Global Blood Bank (Blood Banking) Company, Product Type & Application
3.6 Global Blood Bank (Blood Banking) Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Blood Bank (Blood Banking) Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Blood Bank (Blood Banking) Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 BLOOD BANK (BLOOD BANKING) MARKET BY TYPE
4.1 Blood Bank (Blood Banking) Type Introduction
4.1.1 Whole Blood
4.1.2 Red Blood Cell
4.1.3 Platelet
4.1.4 Plasma
4.1.5 White Blood Cell
4.2 Global Blood Bank (Blood Banking) Sales Value by Type
4.2.1 Global Blood Bank (Blood Banking) Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Blood Bank (Blood Banking) Sales Value by Type (2019-2030)
4.2.3 Global Blood Bank (Blood Banking) Sales Value Share by Type (2019-2030)
5 BLOOD BANK (BLOOD BANKING) MARKET BY APPLICATION
5.1 Blood Bank (Blood Banking) Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Blood Bank (Blood Banking) Sales Value by Application
5.2.1 Global Blood Bank (Blood Banking) Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Blood Bank (Blood Banking) Sales Value by Application (2019-2030)
5.2.3 Global Blood Bank (Blood Banking) Sales Value Share by Application (2019-2030)
6 BLOOD BANK (BLOOD BANKING) MARKET BY REGION
6.1 Global Blood Bank (Blood Banking) Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Blood Bank (Blood Banking) Sales Value by Region (2019-2030)
6.2.1 Global Blood Bank (Blood Banking) Sales Value by Region: 2019-2024
6.2.2 Global Blood Bank (Blood Banking) Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Blood Bank (Blood Banking) Sales Value (2019-2030)
6.3.2 North America Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blood Bank (Blood Banking) Sales Value (2019-2030)
6.4.2 Europe Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Blood Bank (Blood Banking) Sales Value (2019-2030)
6.5.2 Asia-Pacific Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Blood Bank (Blood Banking) Sales Value (2019-2030)
6.6.2 Latin America Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Blood Bank (Blood Banking) Sales Value (2019-2030)
6.7.2 Middle East & Africa Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
7 BLOOD BANK (BLOOD BANKING) MARKET BY COUNTRY
7.1 Global Blood Bank (Blood Banking) Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Blood Bank (Blood Banking) Sales Value by Country (2019-2030)
7.2.1 Global Blood Bank (Blood Banking) Sales Value by Country (2019-2024)
7.2.2 Global Blood Bank (Blood Banking) Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.3.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.4.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.5.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.6.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.7.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.8.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.9.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.10.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.11.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.12.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.13.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.14.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.15.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.16.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.17.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.18.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.19.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.20.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.21.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 American Red Cross
8.1.1 American Red Cross Comapny Information
8.1.2 American Red Cross Business Overview
8.1.3 American Red Cross Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.1.4 American Red Cross Blood Bank (Blood Banking) Product Portfolio
8.1.5 American Red Cross Recent Developments
8.2 Japan Red Cross Society
8.2.1 Japan Red Cross Society Comapny Information
8.2.2 Japan Red Cross Society Business Overview
8.2.3 Japan Red Cross Society Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.2.4 Japan Red Cross Society Blood Bank (Blood Banking) Product Portfolio
8.2.5 Japan Red Cross Society Recent Developments
8.3 New York Blood Center
8.3.1 New York Blood Center Comapny Information
8.3.2 New York Blood Center Business Overview
8.3.3 New York Blood Center Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.3.4 New York Blood Center Blood Bank (Blood Banking) Product Portfolio
8.3.5 New York Blood Center Recent Developments
8.4 Sanquin Blood Supply Foundation
8.4.1 Sanquin Blood Supply Foundation Comapny Information
8.4.2 Sanquin Blood Supply Foundation Business Overview
8.4.3 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.4.4 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Product Portfolio
8.4.5 Sanquin Blood Supply Foundation Recent Developments
8.5 America’s Blood Centers
8.5.1 America’s Blood Centers Comapny Information
8.5.2 America’s Blood Centers Business Overview
8.5.3 America’s Blood Centers Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.5.4 America’s Blood Centers Blood Bank (Blood Banking) Product Portfolio
8.5.5 America’s Blood Centers Recent Developments
8.6 Canadian Blood Services
8.6.1 Canadian Blood Services Comapny Information
8.6.2 Canadian Blood Services Business Overview
8.6.3 Canadian Blood Services Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.6.4 Canadian Blood Services Blood Bank (Blood Banking) Product Portfolio
8.6.5 Canadian Blood Services Recent Developments
8.7 Shire (Baxalta)
8.7.1 Shire (Baxalta) Comapny Information
8.7.2 Shire (Baxalta) Business Overview
8.7.3 Shire (Baxalta) Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.7.4 Shire (Baxalta) Blood Bank (Blood Banking) Product Portfolio
8.7.5 Shire (Baxalta) Recent Developments
8.8 CSL
8.8.1 CSL Comapny Information
8.8.2 CSL Business Overview
8.8.3 CSL Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.8.4 CSL Blood Bank (Blood Banking) Product Portfolio
8.8.5 CSL Recent Developments
8.9 Grifols
8.9.1 Grifols Comapny Information
8.9.2 Grifols Business Overview
8.9.3 Grifols Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.9.4 Grifols Blood Bank (Blood Banking) Product Portfolio
8.9.5 Grifols Recent Developments
8.10 Octapharma
8.10.1 Octapharma Comapny Information
8.10.2 Octapharma Business Overview
8.10.3 Octapharma Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.10.4 Octapharma Blood Bank (Blood Banking) Product Portfolio
8.10.5 Octapharma Recent Developments
8.11 Kedrion
8.11.1 Kedrion Comapny Information
8.11.2 Kedrion Business Overview
8.11.3 Kedrion Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.11.4 Kedrion Blood Bank (Blood Banking) Product Portfolio
8.11.5 Kedrion Recent Developments
8.12 LFB Group
8.12.1 LFB Group Comapny Information
8.12.2 LFB Group Business Overview
8.12.3 LFB Group Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.12.4 LFB Group Blood Bank (Blood Banking) Product Portfolio
8.12.5 LFB Group Recent Developments
8.13 Biotest
8.13.1 Biotest Comapny Information
8.13.2 Biotest Business Overview
8.13.3 Biotest Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.13.4 Biotest Blood Bank (Blood Banking) Product Portfolio
8.13.5 Biotest Recent Developments
8.14 BPL
8.14.1 BPL Comapny Information
8.14.2 BPL Business Overview
8.14.3 BPL Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.14.4 BPL Blood Bank (Blood Banking) Product Portfolio
8.14.5 BPL Recent Developments
8.15 RAAS
8.15.1 RAAS Comapny Information
8.15.2 RAAS Business Overview
8.15.3 RAAS Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.15.4 RAAS Blood Bank (Blood Banking) Product Portfolio
8.15.5 RAAS Recent Developments
8.16 CBPO
8.16.1 CBPO Comapny Information
8.16.2 CBPO Business Overview
8.16.3 CBPO Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.16.4 CBPO Blood Bank (Blood Banking) Product Portfolio
8.16.5 CBPO Recent Developments
8.17 Hualan Bio
8.17.1 Hualan Bio Comapny Information
8.17.2 Hualan Bio Business Overview
8.17.3 Hualan Bio Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.17.4 Hualan Bio Blood Bank (Blood Banking) Product Portfolio
8.17.5 Hualan Bio Recent Developments
8.18 Sichuan Yuanda Shuyang
8.18.1 Sichuan Yuanda Shuyang Comapny Information
8.18.2 Sichuan Yuanda Shuyang Business Overview
8.18.3 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.18.4 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Product Portfolio
8.18.5 Sichuan Yuanda Shuyang Recent Developments
8.19 Abbott
8.19.1 Abbott Comapny Information
8.19.2 Abbott Business Overview
8.19.3 Abbott Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.19.4 Abbott Blood Bank (Blood Banking) Product Portfolio
8.19.5 Abbott Recent Developments
8.20 Beckman Coulter
8.20.1 Beckman Coulter Comapny Information
8.20.2 Beckman Coulter Business Overview
8.20.3 Beckman Coulter Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.20.4 Beckman Coulter Blood Bank (Blood Banking) Product Portfolio
8.20.5 Beckman Coulter Recent Developments
8.21 BD
8.21.1 BD Comapny Information
8.21.2 BD Business Overview
8.21.3 BD Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.21.4 BD Blood Bank (Blood Banking) Product Portfolio
8.21.5 BD Recent Developments
8.22 Bio-Rad Laboratories
8.22.1 Bio-Rad Laboratories Comapny Information
8.22.2 Bio-Rad Laboratories Business Overview
8.22.3 Bio-Rad Laboratories Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.22.4 Bio-Rad Laboratories Blood Bank (Blood Banking) Product Portfolio
8.22.5 Bio-Rad Laboratories Recent Developments
8.23 bioMйrieux
8.23.1 bioMйrieux Comapny Information
8.23.2 bioMйrieux Business Overview
8.23.3 bioMйrieux Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.23.4 bioMйrieux Blood Bank (Blood Banking) Product Portfolio
8.23.5 bioMйrieux Recent Developments
8.24 Cerus
8.24.1 Cerus Comapny Information
8.24.2 Cerus Business Overview
8.24.3 Cerus Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.24.4 Cerus Blood Bank (Blood Banking) Product Portfolio
8.24.5 Cerus Recent Developments
8.25 Haemonetics
8.25.1 Haemonetics Comapny Information
8.25.2 Haemonetics Business Overview
8.25.3 Haemonetics Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.25.4 Haemonetics Blood Bank (Blood Banking) Product Portfolio
8.25.5 Haemonetics Recent Developments
8.26 Immucor
8.26.1 Immucor Comapny Information
8.26.2 Immucor Business Overview
8.26.3 Immucor Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.26.4 Immucor Blood Bank (Blood Banking) Product Portfolio
8.26.5 Immucor Recent Developments
8.27 Fresenius Kabi
8.27.1 Fresenius Kabi Comapny Information
8.27.2 Fresenius Kabi Business Overview
8.27.3 Fresenius Kabi Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.27.4 Fresenius Kabi Blood Bank (Blood Banking) Product Portfolio
8.27.5 Fresenius Kabi Recent Developments
8.28 MacoPharma
8.28.1 MacoPharma Comapny Information
8.28.2 MacoPharma Business Overview
8.28.3 MacoPharma Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.28.4 MacoPharma Blood Bank (Blood Banking) Product Portfolio
8.28.5 MacoPharma Recent Developments
8.29 Ortho-Clinical
8.29.1 Ortho-Clinical Comapny Information
8.29.2 Ortho-Clinical Business Overview
8.29.3 Ortho-Clinical Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.29.4 Ortho-Clinical Blood Bank (Blood Banking) Product Portfolio
8.29.5 Ortho-Clinical Recent Developments
8.30 Terumo BCT
8.30.1 Terumo BCT Comapny Information
8.30.2 Terumo BCT Business Overview
8.30.3 Terumo BCT Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.30.4 Terumo BCT Blood Bank (Blood Banking) Product Portfolio
8.30.5 Terumo BCT Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
10.6 Disclaimer
1.1 Product Definition
1.2 Global Blood Bank (Blood Banking) Market Size, 2019 VS 2023 VS 2030
1.3 Global Blood Bank (Blood Banking) Market Size (2019-2030)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 BLOOD BANK (BLOOD BANKING) MARKET DYNAMICS
2.1 Blood Bank (Blood Banking) Industry Trends
2.2 Blood Bank (Blood Banking) Industry Drivers
2.3 Blood Bank (Blood Banking) Industry Opportunities and Challenges
2.4 Blood Bank (Blood Banking) Industry Restraints
3 BLOOD BANK (BLOOD BANKING) MARKET BY COMPANY
3.1 Global Blood Bank (Blood Banking) Company Revenue Ranking in 2023
3.2 Global Blood Bank (Blood Banking) Revenue by Company (2019-2024)
3.3 Global Blood Bank (Blood Banking) Company Ranking, 2022 VS 2023 VS 2024
3.4 Global Blood Bank (Blood Banking) Company Manufacturing Base & Headquarters
3.5 Global Blood Bank (Blood Banking) Company, Product Type & Application
3.6 Global Blood Bank (Blood Banking) Company Commercialization Time
3.7 Market Competitive Analysis
3.7.1 Global Blood Bank (Blood Banking) Market CR5 and HHI
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.7.3 2023 Blood Bank (Blood Banking) Tier 1, Tier 2, and Tier
3.8 Mergers & Acquisitions, Expansion
4 BLOOD BANK (BLOOD BANKING) MARKET BY TYPE
4.1 Blood Bank (Blood Banking) Type Introduction
4.1.1 Whole Blood
4.1.2 Red Blood Cell
4.1.3 Platelet
4.1.4 Plasma
4.1.5 White Blood Cell
4.2 Global Blood Bank (Blood Banking) Sales Value by Type
4.2.1 Global Blood Bank (Blood Banking) Sales Value by Type (2019 VS 2023 VS 2030)
4.2.2 Global Blood Bank (Blood Banking) Sales Value by Type (2019-2030)
4.2.3 Global Blood Bank (Blood Banking) Sales Value Share by Type (2019-2030)
5 BLOOD BANK (BLOOD BANKING) MARKET BY APPLICATION
5.1 Blood Bank (Blood Banking) Application Introduction
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Others
5.2 Global Blood Bank (Blood Banking) Sales Value by Application
5.2.1 Global Blood Bank (Blood Banking) Sales Value by Application (2019 VS 2023 VS 2030)
5.2.2 Global Blood Bank (Blood Banking) Sales Value by Application (2019-2030)
5.2.3 Global Blood Bank (Blood Banking) Sales Value Share by Application (2019-2030)
6 BLOOD BANK (BLOOD BANKING) MARKET BY REGION
6.1 Global Blood Bank (Blood Banking) Sales Value by Region: 2019 VS 2023 VS 2030
6.2 Global Blood Bank (Blood Banking) Sales Value by Region (2019-2030)
6.2.1 Global Blood Bank (Blood Banking) Sales Value by Region: 2019-2024
6.2.2 Global Blood Bank (Blood Banking) Sales Value by Region (2025-2030)
6.3 North America
6.3.1 North America Blood Bank (Blood Banking) Sales Value (2019-2030)
6.3.2 North America Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blood Bank (Blood Banking) Sales Value (2019-2030)
6.4.2 Europe Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.5 Asia-Pacific
6.5.1 Asia-Pacific Blood Bank (Blood Banking) Sales Value (2019-2030)
6.5.2 Asia-Pacific Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.6 Latin America
6.6.1 Latin America Blood Bank (Blood Banking) Sales Value (2019-2030)
6.6.2 Latin America Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
6.7 Middle East & Africa
6.7.1 Middle East & Africa Blood Bank (Blood Banking) Sales Value (2019-2030)
6.7.2 Middle East & Africa Blood Bank (Blood Banking) Sales Value Share by Country, 2023 VS 2030
7 BLOOD BANK (BLOOD BANKING) MARKET BY COUNTRY
7.1 Global Blood Bank (Blood Banking) Sales Value by Country: 2019 VS 2023 VS 2030
7.2 Global Blood Bank (Blood Banking) Sales Value by Country (2019-2030)
7.2.1 Global Blood Bank (Blood Banking) Sales Value by Country (2019-2024)
7.2.2 Global Blood Bank (Blood Banking) Sales Value by Country (2025-2030)
7.3 USA
7.3.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.3.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.3.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.4 Canada
7.4.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.4.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.4.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.5 Germany
7.5.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.5.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.6 France
7.6.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.6.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.7 U.K.
7.7.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.7.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.8 Italy
7.8.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.8.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.9 Netherlands
7.9.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.9.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.10 Nordic Countries
7.10.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.10.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.11 China
7.11.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.11.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.12 Japan
7.12.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.12.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.13 South Korea
7.13.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.13.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.14 Southeast Asia
7.14.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.14.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.15 India
7.15.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.15.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.16 Australia
7.16.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.16.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.17 Mexico
7.17.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.17.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.18 Brazil
7.18.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.18.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.19 Turkey
7.19.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.19.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.20 Saudi Arabia
7.20.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.20.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
7.21 UAE
7.21.1 Global Blood Bank (Blood Banking) Sales Value Growth Rate (2019-2030)
7.21.2 Global Blood Bank (Blood Banking) Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Blood Bank (Blood Banking) Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 American Red Cross
8.1.1 American Red Cross Comapny Information
8.1.2 American Red Cross Business Overview
8.1.3 American Red Cross Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.1.4 American Red Cross Blood Bank (Blood Banking) Product Portfolio
8.1.5 American Red Cross Recent Developments
8.2 Japan Red Cross Society
8.2.1 Japan Red Cross Society Comapny Information
8.2.2 Japan Red Cross Society Business Overview
8.2.3 Japan Red Cross Society Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.2.4 Japan Red Cross Society Blood Bank (Blood Banking) Product Portfolio
8.2.5 Japan Red Cross Society Recent Developments
8.3 New York Blood Center
8.3.1 New York Blood Center Comapny Information
8.3.2 New York Blood Center Business Overview
8.3.3 New York Blood Center Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.3.4 New York Blood Center Blood Bank (Blood Banking) Product Portfolio
8.3.5 New York Blood Center Recent Developments
8.4 Sanquin Blood Supply Foundation
8.4.1 Sanquin Blood Supply Foundation Comapny Information
8.4.2 Sanquin Blood Supply Foundation Business Overview
8.4.3 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.4.4 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Product Portfolio
8.4.5 Sanquin Blood Supply Foundation Recent Developments
8.5 America’s Blood Centers
8.5.1 America’s Blood Centers Comapny Information
8.5.2 America’s Blood Centers Business Overview
8.5.3 America’s Blood Centers Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.5.4 America’s Blood Centers Blood Bank (Blood Banking) Product Portfolio
8.5.5 America’s Blood Centers Recent Developments
8.6 Canadian Blood Services
8.6.1 Canadian Blood Services Comapny Information
8.6.2 Canadian Blood Services Business Overview
8.6.3 Canadian Blood Services Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.6.4 Canadian Blood Services Blood Bank (Blood Banking) Product Portfolio
8.6.5 Canadian Blood Services Recent Developments
8.7 Shire (Baxalta)
8.7.1 Shire (Baxalta) Comapny Information
8.7.2 Shire (Baxalta) Business Overview
8.7.3 Shire (Baxalta) Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.7.4 Shire (Baxalta) Blood Bank (Blood Banking) Product Portfolio
8.7.5 Shire (Baxalta) Recent Developments
8.8 CSL
8.8.1 CSL Comapny Information
8.8.2 CSL Business Overview
8.8.3 CSL Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.8.4 CSL Blood Bank (Blood Banking) Product Portfolio
8.8.5 CSL Recent Developments
8.9 Grifols
8.9.1 Grifols Comapny Information
8.9.2 Grifols Business Overview
8.9.3 Grifols Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.9.4 Grifols Blood Bank (Blood Banking) Product Portfolio
8.9.5 Grifols Recent Developments
8.10 Octapharma
8.10.1 Octapharma Comapny Information
8.10.2 Octapharma Business Overview
8.10.3 Octapharma Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.10.4 Octapharma Blood Bank (Blood Banking) Product Portfolio
8.10.5 Octapharma Recent Developments
8.11 Kedrion
8.11.1 Kedrion Comapny Information
8.11.2 Kedrion Business Overview
8.11.3 Kedrion Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.11.4 Kedrion Blood Bank (Blood Banking) Product Portfolio
8.11.5 Kedrion Recent Developments
8.12 LFB Group
8.12.1 LFB Group Comapny Information
8.12.2 LFB Group Business Overview
8.12.3 LFB Group Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.12.4 LFB Group Blood Bank (Blood Banking) Product Portfolio
8.12.5 LFB Group Recent Developments
8.13 Biotest
8.13.1 Biotest Comapny Information
8.13.2 Biotest Business Overview
8.13.3 Biotest Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.13.4 Biotest Blood Bank (Blood Banking) Product Portfolio
8.13.5 Biotest Recent Developments
8.14 BPL
8.14.1 BPL Comapny Information
8.14.2 BPL Business Overview
8.14.3 BPL Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.14.4 BPL Blood Bank (Blood Banking) Product Portfolio
8.14.5 BPL Recent Developments
8.15 RAAS
8.15.1 RAAS Comapny Information
8.15.2 RAAS Business Overview
8.15.3 RAAS Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.15.4 RAAS Blood Bank (Blood Banking) Product Portfolio
8.15.5 RAAS Recent Developments
8.16 CBPO
8.16.1 CBPO Comapny Information
8.16.2 CBPO Business Overview
8.16.3 CBPO Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.16.4 CBPO Blood Bank (Blood Banking) Product Portfolio
8.16.5 CBPO Recent Developments
8.17 Hualan Bio
8.17.1 Hualan Bio Comapny Information
8.17.2 Hualan Bio Business Overview
8.17.3 Hualan Bio Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.17.4 Hualan Bio Blood Bank (Blood Banking) Product Portfolio
8.17.5 Hualan Bio Recent Developments
8.18 Sichuan Yuanda Shuyang
8.18.1 Sichuan Yuanda Shuyang Comapny Information
8.18.2 Sichuan Yuanda Shuyang Business Overview
8.18.3 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.18.4 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Product Portfolio
8.18.5 Sichuan Yuanda Shuyang Recent Developments
8.19 Abbott
8.19.1 Abbott Comapny Information
8.19.2 Abbott Business Overview
8.19.3 Abbott Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.19.4 Abbott Blood Bank (Blood Banking) Product Portfolio
8.19.5 Abbott Recent Developments
8.20 Beckman Coulter
8.20.1 Beckman Coulter Comapny Information
8.20.2 Beckman Coulter Business Overview
8.20.3 Beckman Coulter Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.20.4 Beckman Coulter Blood Bank (Blood Banking) Product Portfolio
8.20.5 Beckman Coulter Recent Developments
8.21 BD
8.21.1 BD Comapny Information
8.21.2 BD Business Overview
8.21.3 BD Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.21.4 BD Blood Bank (Blood Banking) Product Portfolio
8.21.5 BD Recent Developments
8.22 Bio-Rad Laboratories
8.22.1 Bio-Rad Laboratories Comapny Information
8.22.2 Bio-Rad Laboratories Business Overview
8.22.3 Bio-Rad Laboratories Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.22.4 Bio-Rad Laboratories Blood Bank (Blood Banking) Product Portfolio
8.22.5 Bio-Rad Laboratories Recent Developments
8.23 bioMйrieux
8.23.1 bioMйrieux Comapny Information
8.23.2 bioMйrieux Business Overview
8.23.3 bioMйrieux Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.23.4 bioMйrieux Blood Bank (Blood Banking) Product Portfolio
8.23.5 bioMйrieux Recent Developments
8.24 Cerus
8.24.1 Cerus Comapny Information
8.24.2 Cerus Business Overview
8.24.3 Cerus Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.24.4 Cerus Blood Bank (Blood Banking) Product Portfolio
8.24.5 Cerus Recent Developments
8.25 Haemonetics
8.25.1 Haemonetics Comapny Information
8.25.2 Haemonetics Business Overview
8.25.3 Haemonetics Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.25.4 Haemonetics Blood Bank (Blood Banking) Product Portfolio
8.25.5 Haemonetics Recent Developments
8.26 Immucor
8.26.1 Immucor Comapny Information
8.26.2 Immucor Business Overview
8.26.3 Immucor Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.26.4 Immucor Blood Bank (Blood Banking) Product Portfolio
8.26.5 Immucor Recent Developments
8.27 Fresenius Kabi
8.27.1 Fresenius Kabi Comapny Information
8.27.2 Fresenius Kabi Business Overview
8.27.3 Fresenius Kabi Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.27.4 Fresenius Kabi Blood Bank (Blood Banking) Product Portfolio
8.27.5 Fresenius Kabi Recent Developments
8.28 MacoPharma
8.28.1 MacoPharma Comapny Information
8.28.2 MacoPharma Business Overview
8.28.3 MacoPharma Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.28.4 MacoPharma Blood Bank (Blood Banking) Product Portfolio
8.28.5 MacoPharma Recent Developments
8.29 Ortho-Clinical
8.29.1 Ortho-Clinical Comapny Information
8.29.2 Ortho-Clinical Business Overview
8.29.3 Ortho-Clinical Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.29.4 Ortho-Clinical Blood Bank (Blood Banking) Product Portfolio
8.29.5 Ortho-Clinical Recent Developments
8.30 Terumo BCT
8.30.1 Terumo BCT Comapny Information
8.30.2 Terumo BCT Business Overview
8.30.3 Terumo BCT Blood Bank (Blood Banking) Revenue and Gross Margin (2019-2024)
8.30.4 Terumo BCT Blood Bank (Blood Banking) Product Portfolio
8.30.5 Terumo BCT Recent Developments
9 CONCLUDING INSIGHTS
10 APPENDIX
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
10.6 Disclaimer
